India Pesticides Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/b1er89zsgrjhlauekbqgwu4p.pdf

Key Takeaways


Margin Breakdown: The Inventory Overhang

D K Jain: "During the last quarters there were serious problems of logistics, whatever raw material we were buying from outside India the logistic problems were too many. So, we had to order bit more of the raw material to avoid any production loss at that time the prices were high. Now, we have to carry over those inventories which is resulting us in the reduction in the margins..."

Demand & Volume: Growth Intact


New Capacity & Product Pipeline

D K Jain: "There is no more space maybe a very small plant here and there Rs.5 Crores - Rs.10 Crores that could be added but not much because the site is more or less full now and we don't want to get too much congested here again from the safety reasons we want it to be relatively very safe plant and with reasonable spaces between the different production grounds."

Hamirpur: The Next Leg

D K Jain: "Tomorrow is the meeting and let us see if we don't get any serious question then we should get it cleared. That is what we are hoping, if we are stuck up here then probably it will get slightly delayed. But if you are able to clear that then we are quite hopeful that in third quarter, last quarter of FY2024 we should be able to produce something."

Revenue & Margin Outlook

Anand Swarup Agarwal: "Minimum 25% level we should be able to handle. We are hoping for more but we are committing 25%."

Guidance & Commitments

CommitmentSpecificsTimeline
High-cost inventory consumptionEntire high-cost inventory utilized, consumed and soldQ3 FY2023
Inventory normalizationInventory days return to normal 70–80 levelBy March 2023
Gross margin recoveryStabilize around 50%; no further deteriorationGradual improvement over next two quarters
Operating EBITDA margin floorMinimum 25%Ongoing, three-to-five-year view
Herbicide plant commissioningDelayed plant operationalEnd-November/first week of December 2022
Two more molecules introducedNew product launchesSecond half of FY2023
FY2024 toplineCertainly more than ~₹1,000 CrFY2024
Hamirpur first block productionFirst manufacturing block producingQ4 FY2024, if clearance obtained imminently
Hamirpur product pipelineAt least 15 products launchedOver four to five years from approval
Hamirpur block ramp-up~50% utilization Year 1, ~100% Year 218–24 months from commissioning
Sandila small additionsOne or two small products, ~400–500 tons, ~₹30 Cr revenueNo specific timeline; registrations already held

Key Metrics

MetricQ2 FY23
Revenue₹253 cr, +38.8% YoY
EBITDA₹55 cr
Gross margin~43%, vs ~48.5% in Q1 FY23
Volume growth~32% YoY
Value growth~39% YoY
Export revenue growth56% YoY
Domestic revenue growth28% YoY
Capacity utilization (technical products)78%
New product revenue contribution₹30 cr in Q2; ₹52 cr in H1 FY23
Raw material import dependency35% of total purchase; China dependency 20% of total purchase
High-cost inventory carried55% of inventory as of 30 Sep
Capex spent in H1 FY23₹35 cr
FY23 capex plan₹70 cr on existing premises, ₹20 cr for Hamirpur
Total technical capacity post-expansion27,500 tons
Medium-term EBITDA margin target~25% (management expectation)